WCN24-2370 Effect of initiation and rapid maximisation of RAASi in patients with CKD and heart failure with reduced ejection fraction – observations from the LIFT study, an ongoing trial
Saved in:
| Main Authors: | Mahrukh Ayesha Ali, Daniel Murphy, Ella Tumelty, Tony Lopez, Simran Parmar, Sabba Hussain, Isaac Chung, Harsha Addada, Riny Paul, Sharirose Abat, Thomas McNally, Irina Chis Ster, Lisa Anderson, Debasish Banerjee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924006910 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN25-4625 MAXIMISATION OF RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITORS IN HEART FAILURE PATIENTS WITH CKD USING POTASSIUM BINDER; PRELIMINARY ANALYSIS OF A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
by: Debasish Banerjee, et al.
Published: (2025-02-01) -
Domiciliary subcutaneous furosemide in patients with CKD and HF: a quality improvement project
by: Laura Bijman, et al.
Published: (2025-04-01) -
WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE
by: Rosa Montero, et al.
Published: (2024-04-01) -
Investigating the glueball-like particle X(2370) in B meson decays
by: Xiao-Tong Li, et al.
Published: (2025-03-01) -
Corrigendum to “WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S251-S252]
by: Rosa Montero, et al.
Published: (2024-09-01)